SHENZHEN, China, Jan. 19, 2012 /PRNewswire-Asia-FirstCall/ --
Mindray Medical International Limited (NYSE: MR), a leading
developer, manufacturer and marketer of medical devices worldwide,
today announced that it will participate in the Arab Health 2012 to
be held between January 23 and 26 in
Dubai, United Arab Emirates.
Arab Health is the most important annual medical exhibition in
the Middle East. Last year,
the event attracted more than 3,000 exhibitors and over 70,000
visitors from more than 60 countries. This year, Mindray will
exhibit more than 50 devices, including six products that were
newly launched in 2011, from its three core product segments:
patient monitoring and life support products, in-vitro diagnostic
products and medical imaging systems. The six new products are:
- The DC-8 color ultrasound system
- The DP-50 black-and-white ultrasound product
- The DP-10 black-and-white ultrasound product
- The new iMEC series patient monitoring system
- The new iPM series patient monitoring system
- The urinary sediment analysis system from Hyssen, which was
acquired by Mindray last year
Mindray's Vice Presidents of International Sales and Marketing,
Ms. Sarah Li and Mr. Richard Yang, will be attending the
conference.
"We are delighted to showcase our latest products and other
promising ones in the pipeline at this important international
exhibition," commented Ms. Li. "These products demonstrate the
success of Mindray's research efforts and our commitment to deliver
high price-to-performance ratio products to the markets
worldwide."
The company will host booths S2E50 and MB10 at the Dubai
International Convention & Exhibition Centre.
About Mindray
We are a leading developer, manufacturer and marketer of medical
devices worldwide. We maintain our global headquarters
in Shenzhen, China, U.S. headquarters in Mahwah, New
Jersey and multiple sales offices in major international
markets. From our main manufacturing and engineering base
in China, we supply through our worldwide distribution network
a broad range of products across three primary business segments,
namely patient monitoring and life support, in-vitro diagnostic,
and medical imaging systems. For more information, please
visit http://ir.mindray.com.
For investor and media inquiries please contact:
In the U.S.:
Hoki Luk
Western Bridge, LLC
Tel: +1-646-808-9150
Email: hoki.luk@westernbridgegroup.com
In China:
Cathy Gao
Mindray Medical International Limited
Tel: +86-755-8188-8023
Email: cathy.gao@mindray.com
SOURCE Mindray Medical International Limited